HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532,165 | +60788.4% | 16,239 | -8.9% | 0.00% | -57.1% |
| Q4 2022 | $874 | -99.9% | 17,826 | -21.4% | 0.01% | -30.0% |
| Q3 2022 | $1,168,000 | +13.3% | 22,669 | +15.7% | 0.01% | +25.0% |
| Q2 2022 | $1,031,000 | +1.5% | 19,594 | +0.4% | 0.01% | +14.3% |
| Q1 2022 | $1,016,000 | +58.5% | 19,507 | +3.8% | 0.01% | +40.0% |
| Q4 2021 | $641,000 | -83.7% | 18,797 | -80.5% | 0.01% | -79.2% |
| Q3 2021 | $3,934,000 | – | 96,340 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |